Best Doctors in the World

Dr. Ali Sadioglu is a double board-certified plastic surgeon. He is known for his skill in both aesthetic and reconstructive breast surgeries. He has nearly 20 years of experience. Dr. Sadioglu has performed thousands of procedures, including rhinoplasty, facelift, liposuction, and breast surgery.

He is dedicated to patient safety and provides personalized care. His patients report high satisfaction rates. Dr. Sadioglu earned advanced degrees from the University of British Columbia and Louisiana State University. He completed his residency at SUNY Health Science Center. His credentials and experience make him a respected leader in plastic surgery.

CANER GELBAL, MD

Birth Date : January 16, 1993 year

Birth Place : İstanbul, Turkey

Education, Awards and Certifications

• Inter High School Olympic Competition,Ankara Science High School Olympic Team Captain,Scientific and Technological Research Council of Turkey(TUBİTAK)-2009 year
• Ankara Science High School-2007-2010 year
• İzmir Science High School – 2010-2011 year 
• Istanbul University School of Medicine – 2017 year 
• Animal Research Certificate – January 2019 year 
• Microsurgery Certificate- May 2019 year 
• Bagcilar Research and Training Hospital , Department  of Plastic,Reconstructive and Aesthetic Surgery  - 2018 year – Current
   

Rotations

November 2018 year - April 2019 year  - General Surgery Rotation - Bagcilar Research and Training Hospital Department of General Surgery

April - May 2019 year - Orthopedia Rotation - Bagcilar Research and Training Hospital Department of Orthopedia

Articles published in nationally-respected journals: 

1. Tatar BE, Gelbal C, Sezgiç M, Karakol P, Uslu C, Kabul S. A Rare Case: Malignant Granular Cell Tumor in Axillary Region.

Oral Presentations in International Meetings

1.Using Mandibular Bony Tissues Which Are Treated with Liquid Nitrogen As Scaffold For Partial Femoral Transplantation in Mandible Reconstruction and Evaluation of Bone Survival: Experimental Rat Femur Transplantation Model 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt 

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

2. The Effect of Centrifuge Duration on Fat Graft Survival 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

3. Are the permanent effects of renal failure not so permanent? 

Percin Karakol, Caner Gelbal, Can Uslu, Burak Ergün Tatar, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

Oral Presentations in national Meetings:

1.Üst ekstremite acil ve elektif vakalarda WALANT’ın kullanımı.                                   

Burak Ergün Tatar, Perçin Karakol, Can Uslu, Caner Gelbal  41. Ulusal Plastik Cerrahi Kurultayı, 26-30 October, 2019 year, Samsun,Turkey

Sidorchuk Yuri Valerievich - plastic surgeon

Education

• 2011-2015 - Rivne State Basic Medical College, specialty "General Medicine", qualification paramedic;
  
• 2015-2021 - Kyiv Medical University named after A.A. Bogomolets, specialty "General Medicine", professional qualification - physician;
  
• 2021-2024 - National Medical Academy of Postgraduate Education named after P. L. Shupik. Specialty "General Surgery" based on the National Institute of Surgery and Transplantation named after A. A. Shalimov.
  

Experience

• 2016-2019 - Kyiv City Clinical Hospital No. 9, Department of Anesthesiology and Intensive Care;
  
• 2018-2019 - Medical Center "Harmony of Health";
  
• 2020-2021 - Medical Center "Medical Practice";
  
• 2020-2023 - Kyiv City Clinical Bureau of Forensic Medical Examination;
  
• from 2023 - Vidnova clinic.
  

Courses and certificates:

• "Center for Special Training" for ACLS (Advance Cardiovascular Life Support - 2022) Kyiv, Ukraine;
  
• "Special Training Center" for ITLS (International Trauma Life Support Advanced) Kyiv, Ukraine;
  
• Participant of the international congress ICANPS 2023 "Modern trends in reconstructive and plastic surgery", Kyiv, Ukraine;
  
• Participant of the international scientific and practical conference 2023 "Current issues of modern plastic and reconstructive surgery", Uzhgorod, Ukraine;
  
• Participant of the conference “Live surgery of aesthetic mammoplasty and oncoplastic breast surgery”, Uzhgorod, Ukraine;
  
• "Dermatoscopy of skin neoplasms", Kyiv, Ukraine;
  
• "Injection treatment with fillers: upper and middle third of the face", Kyiv, Ukraine;
  
• Academy of Advanced Aesthetics. "Blanching": expert knowledge and advanced technologies, Kyiv, Ukraine;
  
• Academy of Advanced Aesthetics - The Art of Lip Correction with Beloteto;
  
• Professional school in online format "Family Doctor Academy", Kyiv, Ukraine;
  
• CPD (continuous professional development). Master class: "Treatment of cancer patients in the epidemiological conditions of 2020", Kyiv, Ukraine;
  
• Scientific and practical conference "Sukharev readings". Topic: "Vascular surgery, phlebology and angiology in the era of COVID-19", Kyiv, Ukraine;
  

Social activities:

• 2020 - rotation to the village of Taramchuk, Maryinsky district, Donetsk region.
  
• 2022 - A volunteer doctor during a full-scale invasion in Kyiv.
  

Achievements and awards:

Decree of the President of Ukraine 419/2022 awarded the medal "For a saved life" dated 17.06. 2022

He was born in Malatya. He completed his medical education at Istanbul University Faculty of Medicine. Between 1994-1998 he worked as a research assistant at Cerrahpaşa Medical Faculty Cardiovascular Surgery and Istanbul University Chest Diseases clinics. 

He completed his Plastic Surgery training at Haydarpaşa Numune Hospital. After working at Dr Lutfi Kırdar Kartal Training and Research Hospital for 10 years, both academically and as a clinician, He has worked as a freelance physician in his clinic since 2014. 

He went to the USA in 2013 and studied at Case Western University in Cleveland at Prof. Dr. Bahman Guyuron’s clinic as an observer. At this university, he increased his experience with world-renowned surgeons, especially in the facelift. 

His main areas of interest in aesthetic surgery are facial rejuvenation, breast and body shaping surgeries. In his professional experience of more than 20 years, 33 scientific studies published in domestic and foreign scientific journals, more than 50 papers presented in different congresses, authoring of a book chapter on wound care, three scientific awards and three theses, in addition to more than 10,000 surgeries so far. Most of his surgeries is about face and neck surgeries.

Education

1991

M.Sc.- Faculty of Medicine-Istanbul University

2000

Ph.D./S. Qualification/ Specialization in Medicine Plastic Reconstructive and Aesthetic SurgeryT.R. Ministry of Health Haydarpasa Numune Training and Research Hospital

Experience

1991-1993

Istanbul University Cerrahpasa Faculty of Medicine, Department of Thoracic and Cardiovascular Surgery (Research Assistant)

1993-1994

Istanbul University Istanbul Faculty of Medicine, Department of Chest Diseases (Research Assistant)

1994-2000

T.R. Ministry of Health Haydarpaşa Numune Training and Research Hospital, Plastic Reconstructive and Aesthetic Surgery Clinic (Research Assistant)

Conditions Treated

• Breast aesthetics: 3000+ Surgery
• Tummy tuck: 100% Satisfaction
• Facelift
• Mifaceliftft
• Facial contour, facial rejuvenation
• Temporal lift
• Almond eye/cat eye
• Eyebrow lift
  + All Aesthetic Plastic Surgery procedures
•  

Professional Memberships

Turkish Plastic, Reconstructive and Aesthetic Surgery Association

Aesthetic Surgery Association

Turkish Society of Reconstructive Microsurgery

Dr. Gerhart Tseslinsky is a board-certified specialist in Internal Medicine, Nephrology and Dialysis at Nordwest Clinic (Krankenhaus). He has extensive experience in diagnosing and treating kidney diseases and hypertension, as well as expertise in dialysis, ultrasound-guided kidney biopsy and kidney transplantation. He is committed to providing excellent patient care and ensuring patient safety, satisfaction, and well-being.

I was born in Naples, born in 1981, and I have the best job in the world. Imagine waking up every morning and knowing that on that day you will make someone's dream come true: you will change a man's life forever, you will give birth to a new woman, you will help a girl achieve happiness, a boy gain self-confidence. I am Silvio Ascione, specialist in Plastic, Reconstructive and Aesthetic Surgery. Son of art, from my father, a great man and great plastic surgeon, I learned the complex and enchanting magic of aesthetic plastic surgery. Nourished by art and medical knowledge, I grew up in operating theatres, always behind my father's back who, like the best of masters, passed on to me, a young disciple, the passion for a profession in which art combines to science to create masterpieces. Graduated in Medicine and Surgery in 2005 from the Second University of Naples, qualified in the first session of 2006 and specialized in Plastic, Reconstructive and Aesthetic Surgery at the School of Specialization of the Second University of Naples directed by Prof. Francesco D'Andrea, I am enrolled in the 'Order of Surgeons of Benevento and I obtained a Master's degree in Oncoplastic Surgery and integrated treatments at the University of Genoa.

My experience in the surgical room, however, began much earlier, and it was an intense, very hard journey, characterized by total dedication, constant updating, continuous training: initially internal at the Department of Plastic, Reconstructive and Aesthetic Surgery of the S.U.N., I frequented then the Department of Reconstructive and Aesthetic Plastic Surgery of the Mediterranean Clinic of Naples affiliated with the “Tor Vergata” University of Rome, the A.O.R.N. Major Burns Center Department, directed by Prof. Roberto D'Alessio, the Trauma Center Department of Prof. Antonio Martin.

I regularly participate in all the main national and international Plastic Surgery conferences to stay constantly updated on the technological innovations offered by the market, the cutting-edge products and instruments to be used for my treatments, the new research and the most recent studies in the field of plastic and aesthetic surgery.

I studied and carried out in-depth internships at universities and hospital centers in Spain, France and North America, gaining extraordinary experience on the most advanced surgical techniques, in particular on facial and breast rejuvenation.

​

MY MISSION

My innate passion for surgery, my attention to the care of the image and the harmony of forms, my obsessive precision and attention to detail, my unstoppable research and updating activity, my decades of experience in the most varied spheres of plastic and aesthetic surgery, working side by side with my specialized team, allow me today to boast a curriculum full of successes and satisfactions and to be able to offer my patients a detailed and scrupulous visit, a precise diagnosis, a treatment plan personalized and efficient intervention, agreed on the basis of the patient's needs and desires, highly effective personal techniques and tools to eliminate all types of blemishes, signs of aging or congenital imperfections, through increasingly less invasive interventions and with increasingly natural results.

​

Experience, professionalism, harmony, naturalness: these are the four key points on which I build a relationship that is first human, then professional, with my patient. The choice of plastic or aesthetic surgery does not only involve the decision to undertake a path of external change. For this reason I dedicate myself with dedication and attention to listening to the discomforts and wishes of each of my patients, so that we can plan together the most appropriate intervention for their needs and to achieve the expected result and to accompany them step by step towards a path of external and internal rebirth

Dr. Seung Hyuck Hong is a leading physician at G Clinic, specializing in lower body contouring and aesthetic treatments. He is known for his expertise in procedures such as liposuction, body slimming injections, and non-invasive body shaping techniques. Dr. Hong is committed to delivering personalized care and achieving natural-looking results for his patients. With a strong academic background and affiliations with major medical associations, he combines clinical precision with cutting-edge techniques to offer safe and effective outcomes.

Education & Training

M.D., Kyung Hee University College of Medicine

Residency & Specialist Training, Kyung Hee University Medical Center

M.S. in Medicine, Kyung Hee University Graduate School of Medicine

Ph.D. in Medicine, Kyung Hee University Graduate School of Medicine

Current Positions

Medical Director, G Clinic

Adjunct Professor, Kyung Hee University College of Medicine

Director of Collaborative Hospitals, Kyung Hee University Medical Center

Director of Collaborative Hospitals, Konkuk University Medical Center

Board-Certified Specialist in Geriatric Medicine

Member, Union Internationale de Médecine Esthétique (UIME)

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Education

- MD / Yonsei University School of Medicine

- Internship, Residency, Department of Neurosurgery / Wonju Severance Hospital

- Specialist / American Board of Minimally Invasive Spine Surgery (FABMISS)

- Fellowship / Royal College of Physicians and Surgeons (RCPS)

Career

- Head of the Department of Neurosurgery / Yangju Military Hospital

- Member of the Korean Society of Neurosurgery

- Member of the Korean Society of Spinal Neurosurgery

- Specialization, Department of Neurosurgery / Urideul Gangnam Hospital (Cheondam)

- Head of the Department of Neurosurgery / Wooridul Daegu Hospital

- Chairman of the Institutional Review Board (IRB) / Wooridul Gangnam (Cheongdam)

- Deputy Editor of Wooridul FTC (Friday Grand Tele-Conference) magazine

Dr. Domenica Trifoglio is an expert in Aesthetic and Wellbeing Medicine.

She graduated in Medicine and Surgery at the University of Rome “Tor Vergata” and, in 2012, obtained the Specialization Diploma in Aesthetic Medicine and Wellbeing at the IAF School in Rome.

You are currently attending the School of Specialization in Physical Medicine and Rehabilitation at the University of Rome “La Sapienza”.

Dr. Trifoglio, after having gained experience in numerous facilities in Rome, now practices as a Hospital Doctor at the Cantonal Hospital Authority in Faido and as an Aesthetic Doctor at LACLINIQUE of Switzerland in Lugano, Switzerland.

Dr. Marc Ulrich Becher is an interventional cardiologist and heart failure specialist at Städtisches Klinikum Solingen. He is known for performing advanced procedures such as coronary angiography, radiofrequency ablation with 3D mapping, carotid angioplasty, and stenting.

Dr. Becher’s clinic carries out about 3,000 to 4,000 diagnostic and therapeutic procedures each year. These include complex coronary interventions, catheter-based valve replacements, and structural heart procedures. He is experienced in using advanced imaging techniques like IVUS and OCT for accurate diagnosis and treatment planning.

Dr. Becher is dedicated to providing thorough and compassionate care. He uses modern therapies for both acute and chronic cardiovascular diseases, focusing on patient safety and positive outcomes.

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Hamdullah Sozen is a gynecologic oncologist with expertise in ovarian, endometrial, and cervical cancers. He is known for his skills in gynecological endoscopic surgery. Dr. Sozen uses minimally invasive techniques that help patients recover faster and improve outcomes.

He is an expert in colposcopy and cervical pathology. He has advanced training in both diagnostic and interventional procedures. Dr. Sozen completed his medical and oncology training at leading Turkish institutions, including Akdeniz University, Zeynep Kamil, and Istanbul Medical Faculty.

He is an active member of international associations such as ESGO and MEMAGO. Dr. Sozen has contributed to women’s cancer care through his clinical work, research, and teaching.

Dr. Levent Dalar is a respected pulmonologist with over 20 years of experience. He specializes in interventional bronchoscopy and rare lung diseases. Dr. Dalar has trained and worked in France, Switzerland, and Turkey. He gained valuable experience at the University of Zürich’s Lung Transplant Unit. His background gives him a broad view of advanced lung care.

Dr. Dalar is known for his work in bronchoscopic techniques. He has diagnosed and treated thousands of complex respiratory cases. His main focus is on interstitial lung diseases and respiratory deficiencies. As a professor, he helps train future specialists at top universities. He is also an active member of ERS, EABIP, SPLF, and GELF, staying involved in the latest developments in respiratory medicine.